LY-4005130
N/A
Report date: 2026/04/17 20:02:02
Base Information
Drug NameLY-4005130
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[8]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesEli Lilly And Company
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A